Cretenism Case Study
Cretenism Case Study
Cretenism Case Study
Submitted by:
Submitted to:
Clinical Instructor
August 4, 2010
I. INTRODUCTION
The term endemic cretinism is used to describe clusters of infants with goiter and
hypothyroidism in a defined geographic area. Such areas were discovered to be low in iodine,
and the cause of endemic cretinism was determined to be iodine deficiency.
The term sporadic cretinism was initially used to describe the random occurrence of
cretinism in non-endemic areas. The cause of these abnormalities was identified as
nonfunctioning or absent thyroid glands. This led to replacement of the descriptive term sporadic
cretinism with the etiologic term congenital hypothyroidism. Treatment with thyroid
replacement therapy was found to elicit some improvement in these infants, although many
remained impaired.
The chances of a child contracting this condition are very small. Data from most countries
with well-established newborn screening programs indicate an incidence of congenital
hypothyroidism of about 1 per 4000 births (United States) so this show just how remote this
condition can be. Some of the highest incidences (1 in 1400-2000 births) have been reported from
various locations in the Middle East. Most studies of congenital hypothyroidism suggest a
female-to-male ratio of a 2:1.
Mental retardation
Growth retardation
Heart problems
If this condition is left untreated then the child may not be able to do simple
tasks as this condition can lead to retardation in the child. Growth will also not be at a
steady rate and other problems will appear and also they will become more severe as the
child ages.
1. Serum TSH
Pituitary production of TSH is measured by a method referred to as IRMA
(immunoradiometric assay).
This rise in TSH represents the pituitary gland's response to a drop in circulating thyroid
hormone; it is usually the first indication of thyroid gland failure.
This means that the thyroid gland fails to produce enough thyroxine and T3 level for
blood circulation
Increased in TBG level shows decrease level of the thyroid hormones in the blood
Expected result: Absence or small thyroid tissue and Decreased iodine uptake
Verify if the client has history of allergic reaction to iodine. The radioactive tracer used
for these tests may contain iodine. However, even if the patient is allergic to iodine, he
will probably be able to have this test because the amount that may be used in the
radioactive tracer is so small that the risk of an allergic reaction is very low.
Before a radioactive iodine uptake (RAIU) test, secure a consent form that says the
patient understands the risks of the test and agree to have it done.
Before an RAIU test, blood tests may be done to measure the amount of thyroid
hormones (TSH, T3, and T4) in blood.
Instruct the patient or care provider that he must not eat for up to 2 hours before the test
and not taking any anti-thyroid medication for 5 to 7 days before the test.
Remove jewelry, dentures, or other metals, because they may interfere with the image.
5. ECG
used to measure the rate and regularity of heartbeats as well as the size and position of
the chambers, the presence of any damage to the heart, and the effects of drugs or
devices used to regulate the heart (such as a pacemaker).
Expected result: Sinus bradycardia and inverted T-wave
9. Cholesterol
Used to check the level of cholesterol-carrying proteins in the blood to determine
impending risk for heart disease
VI. TREATMENT
Cretinism is treatable however it is vitally important that the condition is caught at the
very early stages of the child’s birth. If this condition is caught early then the effects that have
taken place can be reversed.
Replacement therapy with thyroxine is usually the standard treatment given to a child
that has cretinism. Treatment with thyroid hormone promotes normal physical and mental
development. It is essential that treatment be started during the first six weeks of life or
irreversible changes may take place. Once medication starts, the blood levels of T3 and T4 are
monitored to keep the values within a normal range.
Hypothermia r/t decrease Subjective: “Madali syang Hypothermia can also be life
metabolic rate lamigin at lageng malamig ang threatening if left untreated.
kamay nya.” at as verbalized by This can affect blood flow and
the patient’s mother. reduced oxygenation of cells in
the body.
Objective:
cool skin
pallor
body temperature below
normal range
slow capillary refill
Constipation r/t decrease Subjective: This problem is not currently
intestinal peristalsis as “Tatlong beses lang syang health threatening, but it could
evidenced by hypoactive tumae sa isang lingo at madalas be if it were to persist.
bowel sound
na nahihirapan syang ilabas.” as Feces prolonged in intestine
verbalized by the patient’s might produce toxin that could
mother. harm the body.
Objective:
hard, dry stool
hypoactive bowel sound
distended abdomen
straining with defecation
IX. RECOMMENDATION
Prevention
Pregnant women with diagnosed iodine deficiency or problem with thyroid gland is
advised to comply with their medication. Iodine or thyroxine supplementation helps in giving
the fetus adequate hormones needed for growth and development during gestation.
Early Diagnosis
In pregnant women who take radioactive iodine for thyroid cancer, the thyroid gland
may be destroyed in the developing fetus. Infants whose mothers have taken such medicines
should be observed carefully after birth for signs of hypothyroidism. Also, mothers with a
newborn infant are advised to submit their babies for newborn screening test for early detection
of Cretinism.
Nurse should instruct the patient’s care provider about the medications that are
prescribed and their actions. It is also important to inform the family about symptoms that
should be reported to the physician. Also, make sure that they understand that the thyroid
hormone replacement therapy is life long and their compliance is very much needed.
Further Outpatient Care
Laboratory measurements of T4 (total or free T4) and TSH should be repeated 4-6 weeks
after initiation of therapy, then every 1-3 months during the first year of life and every 2-4
months during the second and third years. In children aged 3 years and older, the time interval
between measurements may be increased, depending on the reliability of the patient's caretakers.
As dosage changes are made, testing should be more frequent.